*001722561
*00520230223135450.0
*007cr
*007ta
*008110404s1999    no#           000 0 eng
*00901635cam a2200397 c 4500
*015  $a0008269$2nbf
*019  $bl
*020  $a8277221215$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)990000244064702201
*035  $a(NO-LaBS)14667850(bibid)
*035  $a(NO-TrBIB)000024406
*035  $a(NO-TrBIB)093745753
*035  $a000024406-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*042  $anorbibl
*044  $cno
*060 4$aQZ 200
*080  $a616-006.6.085
*08274$a616.994$qNO-OsNB$24/nor
*1001 $aSemb, Karin Agnethe$0(NO-TrBIB)4531$_100416500
*24510$aStudies of novel anticancer drugs in patients with metastatic malignant melanoma or non-small cell lung cancer :$bincluding studies of pharmacokinetics and transcapillary fluid balance$cby Karin Agnethe Semb
*260  $aOslo$bDepartment of Medical Oncology and Radiotherapy, Department of Tumor Biology, The Norwegian Radium Hospital$bFaculty of Medicine, University of Oslo$c1999
*300  $a1 b. (flere pag.)$bill.$c30 cm
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (dr. med.) - Universitetet i Oslo, 2000
*533  $aElektronisk reproduksjon$b[Norge]$cNasjonalbiblioteket Digital$d2008-09-30
*650 2$aCarcinoma, Non-Small-Cell Lung$xdrug therapy$_53425600
*650 2$aMelanoma$xdrug therapy$_100416600
*650 2$aNeoplasm Metastasis$xdrug therapy$_100416700
*653  $akreft$alungekreft$amelanom$abehandling$afarmakologi$_100416800
*85641$3Fulltekst$uhttps://urn.nb.no/URN:NBN:no-nb_digibok_2008093000043$yNettbiblioteket$zDigital representasjon
*901  $a90
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:990000244064702202$b2021-11-14T20:44:44Z$z990000244064702202
^